Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Taisho patent describes compounds with potential for the treatment for renal disorders, etc.

Jan. 23, 2006

BXL-628 can reduce prostate volume in benign prostatic hyperplasia

Jan. 17, 2006

First launch for Dong-A erectile dysfunction therapy

Jan. 16, 2006

Grants support work in diabetic kidney disease at University of Virginia

Jan. 11, 2006

Anturol completes phase II dose-ranging study

Jan. 5, 2006

FDA approval for Vaprisol in euvolemic hyponatremia

Jan. 2, 2006

New treatments for urological disorders claimed in recent Tanabe Seiyaku and Eisai patents

Dec. 21, 2005

New treatments for urinary incontinence claimed in recent patents

Dec. 13, 2005

Oral PDE5 inhibitor SLx-2101 begins phase IIa trial for erectile dysfunction

Dec. 2, 2005

Korean approval for udenafil in erectile dysfunction

Dec. 1, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...